In the latest session, Caribou Biosciences Inc (NASDAQ: CRBU) closed at $5.14 up 0.39% from its previous closing price of $5.12. In other words, the price has increased by $+0.02 from its previous closing price. On the day, 1347330 shares were traded.
Ratios:
For a deeper understanding of Caribou Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.97 and its Current Ratio is at 11.97. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
On October 31, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $13.
On July 11, 2023, Truist started tracking the stock assigning a Buy rating and target price of $23.Truist initiated its Buy rating on July 11, 2023, with a $23 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRBU now has a Market Capitalization of 464.22M and an Enterprise Value of 162.50M. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.46 while its Price-to-Book (P/B) ratio in mrq is 1.23. Its current Enterprise Value per Revenue stands at 4.71 whereas that against EBITDA is -1.44.
Stock Price History:
Over the past 52 weeks, CRBU has reached a high of $8.59, while it has fallen to a 52-week low of $3.44. The 50-Day Moving Average of the stock is 6.37, while the 200-Day Moving Average is calculated to be 5.72.
Shares Statistics:
For the past three months, CRBU has traded an average of 1.64M shares per day and 1.42M over the past ten days. A total of 88.45M shares are outstanding, with a floating share count of 79.39M. Insiders hold about 12.10% of the company’s shares, while institutions hold 77.97% stake in the company. Shares short for CRBU as of Mar 15, 2024 were 10.07M with a Short Ratio of 6.13, compared to 9.69M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.15% and a Short% of Float of 11.69%.
Earnings Estimates
There are 5 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.4 for the current quarter, with a high estimate of -$0.35 and a low estimate of -$0.44, while EPS last year was -$0.46. The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.4 and low estimates of -$0.46.
Analysts are recommending an EPS of between -$1.6 and -$2.03 for the fiscal current year, implying an average EPS of -$1.74. EPS for the following year is -$2.05, with 6 analysts recommending between -$1.43 and -$2.97.
